Stimuli‐Responsive Polymer Nanoprobes Intended for Fluorescence‐Guided Surgery of Malignant Head‐and‐Neck Tumors and Metastases
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202301183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Robert Pola und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, Prague 6, 162 00, Czech Republic. Hauptthemen laut MEDLINE: Stimuli Responsive Polymers, Head and Neck Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nano‐sized carriers are widely studied as suitable candidates for the advanced delivery of various bioactive molecules such as drugs and diagnostics. Herein, the development of long‐circulating stimuli‐responsive polymer nanoprobes tailored for the fluorescently‐guided surgery of solid tumors is reported. Nanoprobes are designed as long‐circulating nanosystems preferably accumulated in solid tumors due to the Enhanced permeability and retention effect, so they act as a tumor microenvironment‐sensitive activatable diagnostic. This study designs polymer probes differing in the structure of the spacer between the polymer carrier and Cy7 by employing pH‐sensitive spacers, oligopeptide spacers susceptible to cathepsin B‐catalyzed enzymatic hydrolysis, and non‐degradable control spacer. Increased accumulation of the nanoprobes in the tumor tissue coupled with stimuli‐sensitive release behavior and subsequent activation of the fluorescent signal upon dye release facilitated favorable tumor‐to‐background ratio, a key feature for fluorescence‐guided surgery. The probes show excellent diagnostic potential for the surgical removal of intraperitoneal metastasis and orthotopic head and neck tumors with very high efficacy and accuracy. In addition, the combination of macroscopic resection followed by fluorescence‐guided surgery using developed probes enable the identification and resection of most of the CAL33 intraperitoneal metastases with total tumor burden reduced to 97.2%.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, Prague 6, 162 00, Czech Republic.
- Center for Advanced Preclinical Imaging (CAPI), First Faculty of Medicine, Charles University, Salmovská 3, Prague 2, 120 00, Czech Republic.
- University Grenoble Alpes, Institute for Advanced Biosciences, Team Cancer Targets and Experimental Therapeutics, INSERM U1209, CNRS UMR5309, Grenoble, 38100, France.
- Department of Otorhinolaryngology and Head and Neck Surgery, First Faculty of Medicine, Charles University and University Hospital Motol, V Úvalu 84, Prague 5, 150 06, Czech Republic.
ORCID-Profile: Robert Pola, Eliška Grosmanová, Michal Pechar, Dominik Horák, Tereza Krunclová, Jan Pankrác, Maxime Henry, Martin Kaňa, Jan Bouček, Luděk Šefc, Jean-Luc Coll, Tomáš Etrych
Zitieren
APA
Pola, R., Grosmanová, E., Pechar, M., Horák, D., Krunclová, T., Pankrác, J., Henry, M., Kaňa, M., Bouček, J., Šefc, L., Coll, J. L., & Etrych, T. (2023). Stimuli‐Responsive Polymer Nanoprobes Intended for Fluorescence‐Guided Surgery of Malignant Head‐and‐Neck Tumors and Metastases. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202301183
Vancouver
Pola R, Grosmanová E, Pechar M, Horák D, Krunclová T, Pankrác J, et al. Stimuli‐Responsive Polymer Nanoprobes Intended for Fluorescence‐Guided Surgery of Malignant Head‐and‐Neck Tumors and Metastases. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202301183
BibTeX
@article{Pola2023,
author = {Pola, Robert and Grosmanová, Eliška and Pechar, Michal and Horák, Dominik and Krunclová, Tereza and Pankrác, Jan and Henry, Maxime and Kaňa, Martin and Bouček, Jan and Šefc, Luděk and Coll, Jean-Luc and Etrych, Tomáš},
title = {Stimuli‐Responsive Polymer Nanoprobes Intended for Fluorescence‐Guided Surgery of Malignant Head‐and‐Neck Tumors and Metastases},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202301183}
}
EUVIMED